NPPA Caps Retail Prices Of 13 Formulations

Mumbai : The National Pharmaceutical Pricing Authority (NPPA) has fixed retail price of 13 formulations under Drugs Prices Control Order (DPCO) 2013 based on the decision of 83rd Authority Meeting dated January 27, 2021.

The formulations include rosuvastatin + aspirin capsule, telmisartan, cilnidipine and chlorthalidone tablet, rosuvastatin + clopidogrel tablet, rosuvastatin + clopidogrel tablet, mefanamic acid + paracetamol suspension (Pyremol-MF) and vildagliptin + metformin hydrochloride (SR) tablet.

The manufacturer of these formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified. The manufacturer may add goods and services tax only if they have paid actually or it is payable to the government on the retail price as prescribed by NPPA.

The retail price for a pack of these formulations shall be arrived at by the concerned manufacturer in accordance with the retail price specified as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller (SDC) and dealers.

As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

The retail price fixed is applicable only to the individual manufacturer/marketer as specified i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO 2013.

In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

  • Related Posts

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Prices of nearly 900 essential medicines, including painkillers and antibiotics, are set to rise by around 0.65 per cent starting 1 April following a directive from India’s drug pricing regulator.…

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    The court also asked Dr Reddy’s to inform it by Friday whether it is willing to drop the “Olymviq” brand name, as the matter centres around alleged trademark similarity with…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

    24-year-old woman dies during surgery; Five UP doctors booked for negligence

    24-year-old woman dies during surgery; Five UP doctors booked for negligence